Subject: Concerns Regarding the Swift Prohibition of PFAS We understand the concerns surrounding persistent substances and their accumulation over time.

Submission to: European Chemicals Agency (ECHA) Committee for Socio-Economic Analysis (SEAC) Concerning: Consultation related to the Annex XV Restriction Proposal on per- and polyfluoroalkyl substances (PFAS). 18 September 2023 Submitting organisation The Fire Industry Association (FIA) is the United Kingdom's largest trade body related to fire protection matters representing well over 1000 companies (from small to the largest multi-nationals) involved in fire protection for residential, commercial and industrial applications in the UK, Europe and indeed worldwide.

BioPhorum BioPhorum Response to the Annex XV report on the proposal for universal restrictions (Part II) Contact: @biophorum.com Connect Collaborate Accelerate TM page 1 Opening Statement: The Biopharmaceutical (BioPharma) industry, represented here by BioPhorum, acknowledge the concerns raised regarding the potential adverse effects of various Per- and polyfluoroalkyl substances (PFAS) materials on human health and the environment, and fully support efforts to minimise and mitigate the presence of these, and other potential substances of concern in our manufacturing processes and products.

Vorabverffentlichung: Untersuchungsergebnisse zu PFAS in Coffee- to-go-Bechern und anderen Streetfoodverpackungen Andrea Dombrowski (Goethe-Universitt Frankfurt), Dr.

PrimarySkin IrritationTest with T-3874 in Albino Rabbits Experiment No: Conducted At: Dates Conducted: Conducted By: Reviewed By: 0386EB0135 Pathology and Toxicology Riker Laboratories,Inc.

Aug 1, 2023 Comment on Proposed Restriction of PFAS Japan Valve Manufacturers' Association (JVMA) Japan Valve Manufacturers' Association (JVMA) appreciates the opportunity to provide comments to the PFAS restriction proposal. 1.

Linde feedback and concerns on the proposed PFAS restriction Linde as one of the refrigerant distributors in Northern Europe is fully committed to minimizing release of PFAS to the environment by continuously investing in circular economy for refrigerants including refrigerants that contain PFAS with the aim to keep refrigerants in a closed circle until they reach the end of their life cycle and move to our waste management partners where a well-controlled process is applied which destroys PFAS by destroying fluorocarbon structure and even enables recovery of hydrofluoric acid for reuse.

KION GROUP Page 1 KION GROUP c/o Fenwick-Linde SAS I 1 Rue de Marechal de Lattre de Tassigny I 78854 Elancourt Cedex I France Contribution to PFAS consultation submitted by Dr.

PFAS restriction proposal SolarPower Europe position paper SolarPower Europe acknowledges the rationale behind the proposed restriction on PFAS.

* * * * pneurop ** * * * FRANKFURT, 2023-09-04 Pneurop committee 5 "Vacuum technology" (PN 5) Draft position paper on the planned restriction of PFAS Version 2.1 Table of content 1.

MICROBICS MICROTOX@) TOXICRTY TEST TEST SUBSTANCE Identity:Perfluorooctanoiaccid,ammonium salt;may alsobe referredto as PFOA ammonium salt,Ammonium perfluorooctanoateP,FO, FC-1 16, FC-1 26, FC-1 69, FC-1 43 or as the major component of FC-1015 or FC-1 015-X.

TOXICITY TO AQUATIC PLANTS TEST SUBSTANCE Identity:A mixturecontainingperfluorooctanesulfonawthei,ch may alsobe referredtoas PFOS, FC-95 or as a component of FC-201AF. (1Octanesulfoniaccid)(CAS # 2795-39-3).

ACTIVATED SLUDGE RESPIRATION INHIBITION TEST TEST SUBSTANCE Identity:A mixturecontainingperfluorooctanesulfonatweh,ich may alsobe referredtoas PFOS, FC-95 or as a component of FC-201AF. (1Octanesulfonicacid)(CAS # 2795-39-3).

ACUTE TOXICITY TO FISH (FATHEAD MINNOW) TEST SUBSTANCE Identity:A mixturecontainingperfluorooctanesulfonatweh,ich may alsobe referredtoas PFOS, FC-95, or as a component ofL-4647. (1Octanesulfonicacid)(CAS # 2795-39-3).

Acute ocular Irritation Test with T-2997CoC in Albino Rabbits Experiment No-: Conducted At: Dates Conducted: Conducted By: 0682EB0009 Safety Evaluation Laboratory Riker Laboratories, Inc.